T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $1.71M | ﹤0.01% |
6,519
| – | – |
|
1627
Crane NXT
CXT
$2.97B
| $1.71M | ﹤0.01% |
27,768
+1,124
| +4% | +$68.9K |
|
|
CWAN
1628
DELISTED
Clearwater Analytics
CWAN
| $1.7M | ﹤0.01% |
91,762
+48,189
| +111% | +$869K |
|
|
ARCH
1629
DELISTED
Arch Resources, Inc.
ARCH
| $1.7M | ﹤0.01% |
11,166
+425
| +4% | +$68.3K |
|
1630
Liberty Media Series A
FWONA
$24.1B
| $1.7M | ﹤0.01% |
26,390
+1,129
| +4% | +$71.8K |
|
1631
Valley National Bancorp
VLY
$8.29B
| $1.69M | ﹤0.01% |
242,210
+13,811
| +6% | +$101K |
|
|
SIX
1632
DELISTED
Six Flags Entertainment Corp.
SIX
| $1.69M | ﹤0.01% |
50,993
+1,228
| +2% | +$32.3K |
|
1633
Community Bank
CBU
$3.45B
| $1.68M | ﹤0.01% |
35,654
+1,435
| +4% | +$64.9K |
|
1634
iShares Russell 2000 ETF
IWM
$82.7B
| $1.68M | ﹤0.01% |
8,296
-1,678
| -17% | -$339K |
|
1635
Progyny
PGNY
$2.02B
| $1.68M | ﹤0.01% |
58,820
+3,908
| +7% | +$118K |
|
1636
Dime Commercial Bancshares
DCOM
$1.81B
| $1.68M | ﹤0.01% |
82,312
+1,063
| +1% | +$20K |
|
1637
Ziff Davis
ZD
$1.9B
| $1.68M | ﹤0.01% |
30,489
+1,173
| +4% | +$64.5K |
|
1638
Renasant Corp
RNST
$3.98B
| $1.68M | ﹤0.01% |
54,815
+1,194
| +2% | +$35.5K |
|
1639
Vista Energy
VIST
$7.58B
| $1.67M | ﹤0.01% |
36,770
+31,600
| +611% | +$1.4M |
|
1640
ICU Medical
ICUI
$4.59B
| $1.67M | ﹤0.01% |
14,024
+2,309
| +20% | +$243K |
|
1641
Corcept Therapeutics
CORT
$12.3B
| $1.66M | ﹤0.01% |
51,135
+2,709
| +6% | +$74.2K |
|
1642
NMI Holdings
NMIH
$3.43B
| $1.66M | ﹤0.01% |
48,824
-8,815
| -15% | -$284K |
|
1643
Safety Insurance
SAFT
$1.52B
| $1.66M | ﹤0.01% |
22,055
+1,863
| +9% | +$146K |
|
1644
MillerKnoll
MLKN
$1.62B
| $1.65M | ﹤0.01% |
62,233
+1,583
| +3% | +$41.6K |
|
1645
ACV Auctions
ACVA
$1.35B
| $1.65M | ﹤0.01% |
90,217
+12,670
| +16% | +$228K |
|
1646
Marqeta
MQ
$1.71B
| $1.64M | ﹤0.01% |
74,910
+3,565
| +5% | +$78.5K |
|
1647
Blackstone Mortgage Trust
BXMT
$2.46B
| $1.64M | ﹤0.01% |
93,991
+5,947
| +7% | +$107K |
|
1648
Harmonic Inc
HLIT
$1.51B
| $1.64M | ﹤0.01% |
139,108
+3,664
| +3% | +$41.4K |
|
1649
Oil States International
OIS
$544M
| $1.63M | ﹤0.01% |
367,494
+313,873
| +585% | +$1.51M |
|
1650
Pegasystems
PEGA
$5.35B
| $1.63M | ﹤0.01% |
53,906
-206,656
| -79% | -$6.19M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.